- Home
- RGNX vs UTL Comparison
RGNX vs UTL Comparison
Compare RGNX & UTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RGNX | UTL |
|---|---|---|
| Founded | 2008 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Power Generation |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 793.5M | 944.1M |
| IPO Year | 2015 | 1995 |
Fundamental Metrics
Financial Performance| Metric | RGNX | UTL |
|---|---|---|
| Price | $7.13 | $54.89 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 12 | 3 |
| Target Price | $23.58 | ★ $54.00 |
| AVG Volume (30 Days) | ★ 1.3M | 108.1K |
| Earning Date | 11-05-2026 | 11-02-2026 |
| Dividend Yield | N/A | ★ 3.55% |
| EPS Growth | ★ 18.08 | 1.37 |
| EPS | N/A | ★ 2.11 |
| Revenue | $10,393,000.00 | ★ $536,000,000.00 |
| Revenue This Year | N/A | $16.49 |
| Revenue Next Year | $22.42 | N/A |
| P/E Ratio | ★ N/A | $25.40 |
| Revenue Growth | ★ 126.48 | 8.33 |
| 52 Week Low | $5.46 | $46.91 |
| 52 Week High | $16.19 | $57.26 |
Technical Indicators
Market Signals| Indicator | RGNX | UTL |
|---|---|---|
| Relative Strength Index (RSI) | 41.44 | 65.94 |
| Support Level | $6.96 | $52.10 |
| Resistance Level | $7.32 | $54.96 |
| Average True Range (ATR) | 0.48 | 1.04 |
| MACD | 0.04 | 0.31 |
| Stochastic Oscillator | 21.85 | 95.93 |
Price Performance
Historical ComparisonAbout RGNX REGENXBIO Inc.
Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.
About UTL UNITIL Corporation
Unitil Corp through its subsidiaries engages in the distribution of electricity and natural gas in its service territories in the states of New Hampshire, Massachusetts and Maine. Its natural gas operations include gas distribution utility operations and interstate gas transmission pipeline operations. It also engages in interstate natural gas transmission pipeline company, operating approximately 85 miles of underground gas transmission pipeline located in Maine and New Hampshire. The company's segments include Electric and Gas.